ACSL1 anticorps (AA 1-100)
-
- Antigène Voir toutes ACSL1 (Acsl1) Anticorps
- ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
-
Épitope
- AA 1-100
-
Reactivité
- Humain, Souris, Rat, Primate
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ACSL1 est non-conjugé
-
Application
- Western Blotting (WB)
- Fonction
- Rabbit polyclonal antibody raised against synthetic peptide of ACSL1.
- Réactivité croisée
- Humain, Souris, Primate, Rat
- Immunogène
- A synthetic peptide corresponding to amino acids 1-100 of human ACSL1.
- Top Product
- Discover our top product Acsl1 Anticorps primaire
-
-
- Indications d'application
-
Western Blot (1 μg/mL)
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In PBS (30 % glycerol, 0.09 % sodium azide)
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Store at 4°C for short term. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes." dans: Journal of lipid research, Vol. 47, Issue 3, pp. 665-72, (2006) (PubMed).
: "Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo." dans: American journal of physiology. Endocrinology and metabolism, Vol. 291, Issue 4, pp. E737-44, (2006) (PubMed).
: "
-
Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes." dans: Journal of lipid research, Vol. 47, Issue 3, pp. 665-72, (2006) (PubMed).
-
- Antigène
- ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
- Autre désignation
- ACSL1 (Acsl1 Produits)
- Synonymes
- anticorps ACS1, anticorps FACL1, anticorps FACL2, anticorps LACS, anticorps LACS1, anticorps LACS2, anticorps Acas, anticorps Acas1, anticorps Acs, anticorps FACS, anticorps Facl2, anticorps ACS, anticorps COAA, anticorps zgc:110081, anticorps CER8, anticorps ECERIFERUM 8, anticorps LONG-CHAIN ACYL-COA SYNTHASE 1, anticorps T8I13.8, anticorps F13F21.14, anticorps F13F21_14, anticorps LATERAL ROOT DEVELOPMENT 2, anticorps LRD2, anticorps long-chain acyl-CoA synthetase 2, anticorps acyl-CoA synthetase long chain family member 1, anticorps acyl-CoA synthetase long-chain family member 1, anticorps acyl-CoA synthetase long chain family member 1a, anticorps AMP-dependent synthetase and ligase family protein, anticorps long-chain acyl-CoA synthetase 2, anticorps ACSL1, anticorps Acsl1, anticorps acsl1a, anticorps LACS1, anticorps LACS2
- ID gène
- 2180
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-